Login or Sign Up
Concord Biotech Ltd. Corporate Actions
15:58 Sep 12
Concord Biotech Ltd.
Sector Pharmaceuticals & Biotechnology
Industry Biotechnology
Concord Biotech Ltd.
Industry Biotechnology
15:58 Sep 12
Quality
64/100
High Financial Strength
Valuation
28/100
Expensive Valuation
Technical
36/100
Technically Neutral
Strength
7
Weakness
8
Opportunity
0
Threats
1
0.65 %
Dividend Yield
17.15K
Market Cap (Cr)
43.37
RSI
44.08 %
Promoter Holding
30.96 %
Net Profit Margin
| Ex-Date | Type | Description | Record Date | Ratio | Dividend Type |
|---|---|---|---|---|---|
| 03-Sep-2025 | Dividend | 10.70/share@1,070.00% | 03-Sep-2025 | 1,070.00 | Final |
| 21-Jun-2024 | Dividend | 8.75/share@875.00% | 22-Jun-2024 | 875.00 | Final |
Download Our App On:
Back
OTP sent to your mobile number/email. Please enter it below to verify.
